Sathe, C., Accordino, M. K., DeStephano, D., Shah, M., Wright, J. D., & Hershman, D. L. (2023). Social determinants of health and CDK4/6 inhibitor use and outcomes among patients with metastatic breast cancer. Breast Cancer Research and Treatment, 200(1), 85–92. https://doi.org/10.1007/s10549-023-06957-5

Odai-Afotey, A., Lederman, R. I., Ko, N. Y., Gagnon, H., Fikre, T., Gundersen, D. A., Revette, A. C., Hershman, D. L., Crew, K. D., Keating, N. L., & Freedman, R. A. (2023). Breast cancer treatment receipt and the role of financial stress, health literacy, and numeracy among diverse breast cancer survivors. Breast Cancer Research and Treatment, 200(1), 127–137. https://doi.org/10.1007/s10549-023-06960-w

Acheampong, T., Rodríguez, C. B., O’Neill, S. C., Agovino, M., Argov, E. J. L., & Tehranifar, P. (2023). Scientific uncertainty and perceived mammography benefits in women screened for breast cancer. Cancer Causes & Control, 34(7), 611–619. https://doi.org/10.1007/s10552-023-01697-9

Sun, X., Zhang, Q., Kadier, K., Hu, P., Liu, X., Liu, J., Yan, Y., Sun, C., Yau, V., Lowe, S., Meng, M., Liu, Z., & Zhou, M. (2023). Association between diabetes status and breast cancer in US adults: findings from the US National Health and Nutrition Examination Survey. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1059303

Matar-Ujvary, R., Haglich, K., Flanagan, M. R., Fuzesi, S., Sevilimedu, V., Nelson, J. A., & Gemignani, M. L. (2023). The Impact of Breast-Conserving Surgery Re-excision on Patient-Reported Outcomes Using the BREAST-Q. Annals of Surgical Oncology, 30(9), 5341–5349. https://doi.org/10.1245/s10434-023-13592-3

Siddique, M., Liu, M., Duong, P., Jambawalikar, S., & Ha, R. (2023). Deep Learning Approaches with Digital Mammography for Evaluating Breast Cancer Risk, a Narrative Review. Tomography, 9(3), 1110–1119. https://doi.org/10.3390/tomography9030091

Asadourian, P. A., Chen, Y., Jung, W., Wang, M. L., Koerner, A., Qin, N., de Freitas, D., Chinta, M., Andy, C., Rohde, C. H., & Otterburn, D. M. (2023). Return of the Flap; The Empire State Mandate. Annals of Plastic Surgery, 90(6S), S598–S606. https://doi.org/10.1097/sap.0000000000003490

O’Mahony, D. G., Ramus, S. J., Southey, M. C., Meagher, N. S., Hadjisavvas, A., John, E. M., Hamann, U., Imyanitov, E. N., Andrulis, I. L., Sharma, P., Daly, M. B., Hake, C. R., Weitzel, J. N., Jakubowska, A., Godwin, A. K., Arason, A., Bane, A., Simard, J., … Soucy, P. (2023). Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2. British Journal of Cancer, 128(12), 2283–2294. https://doi.org/10.1038/s41416-023-02263-5

Sayed, S., Koka, H., Abubakar, M., Gardner, K., Salgado, R., Moloo, Z., Caban-Ureña, A. B., Rosen, D., Castro, P., Saleh, M., Shaikh, A. J., Shah, J., Figueroa, J., Makokha, F., Ha, H. K., Wang, Z., Magangane, P., Naidoo, R., Ngundo, V., … Govender, D. (2023). Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics. Breast Cancer Research and Treatment, 199(2), 401–413. https://doi.org/10.1007/s10549-023-06921-3

Moran, G. W., Steinman, J. B., Tillotson, C. V., Carpenter, C. P., Hays, T., Ham, J. N., & Li, B. (2023). Virilization of a 46,XX Fetus Following Aromatase Inhibitor Treatment of Breast Cancer. Pediatrics, 151(6). https://doi.org/10.1542/peds.2022-060568

Brett, J. O., Dubash, T. D., Johnson, G. N., Niemierko, A., Mariotti, V., Kim, L. S. L., Xi, J., Pandey, A., Dunne, S., Nasrazadani, A., Lloyd, M. R., Kambadakone, A., Spring, L. M., Micalizzi, D. S., Onozato, M. L., Che, D., Nayar, U., Brufsky, A., Kalinsky, K., … Wander, S. A. (2023). A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression. JCO Precision Oncology, 7. https://doi.org/10.1200/po.22.00532

Dix-Peek, T., Phakathi, B. P., van den Berg, E. J., Dickens, C., Augustine, T. N., Cubasch, H., Neugut, A. I., Jacobson, J. S., Joffe, M., Ruff, P., & Duarte, R. A. B. (2023). Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer. Breast Cancer Research and Treatment, 199(1), 1–12. https://doi.org/10.1007/s10549-023-06886-3

Hwong, A. R., Vittinghoff, E., Thomas, M., Hermida, R., Walkup, J., Crystal, S., Olfson, M., & Mangurian, C. (2023). Breast Cancer Screening Rates Among Medicaid Beneficiaries With Schizophrenia. Psychiatric Services, 74(5), 497–504. https://doi.org/10.1176/appi.ps.20220163

Lawrence, W. R., McDonald, J. A., Williams, F., Shiels, M. S., Freedman, N. D., Lin, Z., & Magnani, J. W. (2023). Stressful Life Events, Social Support, and Incident Breast Cancer by Estrogen Receptor Status. Cancer Prevention Research, 16(5), 259–267. https://doi.org/10.1158/1940-6207.capr-22-0472

Haslam, D. E., John, E. M., Knight, J. A., Li, Z., Buys, S. S., Andrulis, I. L., Daly, M. B., Genkinger, J. M., Terry, M. B., & Zhang, F. F. (2023). Diet Quality and All-Cause Mortality in Women with Breast Cancer from the Breast Cancer Family Registry. Cancer Epidemiology, Biomarkers & Prevention, 32(5), 678–686. https://doi.org/10.1158/1055-9965.epi-22-1198

Serrano, D., Gandini, S., Thomas, P., Crew, K. D., Kumar, N. B., Vornik, L. A., Lee, J. J., Veronesi, P., Viale, G., Guerrieri-Gonzaga, A., Lazzeroni, M., Johansson, H., D’Amico, M., Guasone, F., Spinaci, S., Bertelsen, B.-E., Mellgren, G., Bedrosian, I., Weber, D., … Bonanni, B. (2023). Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor–Positive Breast Cancer. JAMA Oncology, 9(5), 664. https://doi.org/10.1001/jamaoncol.2023.0089

Gleckler, L., Roy, N., Bernstein, M., Balija, T. M., LaPlaca, C., Nevid, D. R., Lee, J. H., Port, E., & Bernik, S. F. (2023). Impact of Preoperative Extramammary Findings in Patients with Newly Diagnosed Breast Cancer. Journal of the American College of Surgeons, 236(5), 1047–1053. https://doi.org/10.1097/xcs.0000000000000605

El-Sadoni, M., Shboul, S. A., Alhesa, A., Shahin, N. A., Alsharaiah, E., Ismail, M. A., Ababneh, N. A., Alotaibi, M. R., Azab, B., & Saleh, T. (2023). A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy. Cancer Chemotherapy and Pharmacology, 91(4), 345–360. https://doi.org/10.1007/s00280-023-04523-w

Kumthekar, P. U., Avram, M. J., Lassman, A. B., Lin, N. U., Lee, E., Grimm, S. A., Schwartz, M., Bell Burdett, K. L., Lukas, R. V., Dixit, K., Perron, I., Zhang, H., Gradishar, W. J., Pentsova, E. I., Jeyapalan, S., Groves, M. D., Melisko, M., & Raizer, J. J. (2022). A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics. Neuro-Oncology, 25(3), 557–565. https://doi.org/10.1093/neuonc/noac195

Sivakumar, S., Jin, D. X., Rathod, R., Ross, J., Cantley, L. C., Scaltriti, M., Chen, J. W., Hutchinson, K. E., Wilson, T. R., Sokol, E. S., & Vasan, N. (2023). Genetic Heterogeneity and Tissue-specific Patterns of Tumors with MultiplePIK3CAMutations. Clinical Cancer Research, 29(6), 1125–1136. https://doi.org/10.1158/1078-0432.ccr-22-2270

Sompuram, S. R., Vani, K., Ryan, L., Johnson, C., Szabolcs, M., Peruyero, L., Balaton, A., Pierrot, S., Joseph, L., Pilichowska, M., Naber, S., Goldsmith, J., Green, S., & Bogen, S. A. (2023). Validation of Linear Range HER2/Estrogen Receptor/Progesterone Receptor IHControls for Daily Quality Assurance. American Journal of Clinical Pathology, 159(3), 274–282. https://doi.org/10.1093/ajcp/aqac163

Mavaddat, N., Ficorella, L., Carver, T., Lee, A., Cunningham, A. P., Lush, M., Dennis, J., Tischkowitz, M., Downes, K., Hu, D., Hahnen, E., Schmutzler, R. K., Stockley, T. L., Downs, G. S., Zhang, T., Chiarelli, A. M., Bojesen, S. E., Liu, C., Chung, W. K., … Easton, D. F. (2023). Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model. Cancer Epidemiology, Biomarkers & Prevention, 32(3), 422–427. https://doi.org/10.1158/1055-9965.epi-22-0756

Beauchemin, M. P., DeStephano, D., Raghunathan, R., Harden, E., Accordino, M., Hillyer, G. C., Kahn, J. M., May, B. L., Mei, B., Rosenblat, T., Law, C., Elkin, E. B., Kukafka, R., Wright, J. D., & Hershman, D. L. (2023). Implementation of Systematic Financial Screening in an Outpatient Breast Oncology Setting. JCO Clinical Cancer Informatics, 7. https://doi.org/10.1200/cci.22.00172

Mapanga, W., Norris, S. A., Craig, A., Ayeni, O. A., Chen, W. C., Jacobson, J. S., Neugut, A. I., Ruff, P., Cubasch, H., O’Neil, D. S., Buccimazza, I., Čačala, S., Stopforth, L. W., Farrow, H. A., Nietz, S., Phakathi, B., Chirwa, T., McCormack, V. A., & Joffe, M. (2023). Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort. PLOS ONE, 18(2), e0281916. https://doi.org/10.1371/journal.pone.0281916

Goldberg, M., McDonald, J. A., Houghton, L. C., Andrulis, I. L., Knight, J. A., Bradbury, A. R., Schwartz, L. A., Buys, S. S., Frost, C. J., Daly, M. B., John, E. M., Keegan, T. H. M., Chung, W. K., Wei, Y., & Terry, M. B. (2022). Maternal and prenatal factors and age at thelarche in the LEGACY Girls Study cohort: implications for breast cancer risk. International Journal of Epidemiology, 52(1), 272–283. https://doi.org/10.1093/ije/dyac108

Levy, A. S., Murphy, A. I., Ishtihar, S., Peysakhovich, A., Taback, B., Grant, R. T., Ascherman, J. A., Feldman, S., & Rohde, C. H. (2022). Lymphatic Microsurgical Preventive Healing Approach for the Primary Prevention of Lymphedema: A 4-Year Follow-Up. Plastic & Reconstructive Surgery, 151(2), 413–420. https://doi.org/10.1097/prs.0000000000009857

Ayeni, O. A., Chiwambutsa, S., Chen, W. C., Kapungu, N., Kanji, C., Thelingwani, R., Murugan, N., Mathiba, R., Phakathi, B., Nietz, S., Ramiah, D., O’Neil, D. S., Jacobson, J. S., Ruff, P., Cubasch, H., Chirwa, T., Joffe, M., Masimirembwa, C., & Neugut, A. I. (2022). The impact of HIV on non-adherence for tamoxifen among women with breast cancer in South Africa. Breast Cancer Research and Treatment, 197(3), 647–659. https://doi.org/10.1007/s10549-022-06835-6

Tshiaba, P. T., Ratman, D. K., Sun, J. M., Tunstall, T. S., Levy, B., Shah, P. S., Weitzel, J. N., Rabinowitz, M., Kumar, A., & Im, K. M. (2023). Integration of a Cross-Ancestry Polygenic Model With Clinical Risk Factors Improves Breast Cancer Risk Stratification. JCO Precision Oncology, 7. https://doi.org/10.1200/po.22.00447

Meernik, C., Jorgensen, K., Wu, C.-F., Murphy, C. C., Baker, V. L., Brady, P. C., Nitecki, R., Nichols, H. B., & Rauh-Hain, J. A. (2023). Disparities in the use of assisted reproductive technologies after breast cancer: a population-based study. Breast Cancer Research and Treatment, 198(1), 149–158. https://doi.org/10.1007/s10549-022-06857-0

Shah, Y. B., Kjelstrom, S., Martinez, D., Leitenberger, A., Manasseh, D., Bollmann‐Jenkins, M., Partridge, A., Kaklamani, V., Chlebowski, R., Larson, S., & Weiss, M. (2022). Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients. Cancer Medicine, 12(3), 3577–3588. Portico. https://doi.org/10.1002/cam4.5184

Zeleke, T. Z., Pan, Q., Chiuzan, C., Onishi, M., Li, Y., Tan, H., Alvarez, M. J., Honan, E., Yang, M., Chia, P. L., Mukhopadhyay, P., Kelly, S., Wu, R., Fenn, K., Trivedi, M. S., Accordino, M., Crew, K. D., Hershman, D. L., Maurer, M., … Silva, J. (2022). Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nature Cancer, 4(2), 257–275. https://doi.org/10.1038/s43018-022-00489-5

Zhang, Y., Sun, C., Yau, V., Chen, S., Yang, Q., Chen, W., Lowe, S., Bentley, R., & Ouyang, Z. (2023). Clinical Features and Prognosis of Uncommon Metastatic Breast Cancer: A Retrospective Analysis of 82 Cases. Technology in Cancer Research & Treatment, 22. https://doi.org/10.1177/15330338231184990

Zhang, J., McGuinness, J. E., He, X., Jones, T., Silverman, T., Guzman, A., May, B. L., Kukafka, R., & Crew, K. D. (2023). Breast Cancer Risk and Screening Mammography Frequency Among Multiethnic Women. American Journal of Preventive Medicine, 64(1), 51–60. https://doi.org/10.1016/j.amepre.2022.08.004

Lee Argov, E. J., Rodriguez, C. B., Agovino, M., Wei, Y., Shelton, R. C., Kukafka, R., Schmitt, K. M., Desperito, E., Terry, M. B., & Tehranifar, P. (2022). Breast cancer worry, uncertainty, and perceived risk following breast density notification in a longitudinal mammography screening cohort. Breast Cancer Research, 24(1). https://doi.org/10.1186/s13058-022-01584-2

Cogan, J. C., Raghunathan, R. R., Beauchemin, M. P., Accordino, M. K., Huang, Y., Elkin, E. B., Melamed, A., Wright, J. D., & Hershman, D. L. (2022). New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer. JNCI: Journal of the National Cancer Institute, 114(12), 1698–1705. https://doi.org/10.1093/jnci/djac170

Wiechmann, L., & Friedlander, L. C. (2022). Management of Radiographic Lesions of the Breast. Surgical Clinics of North America, 102(6), 1031–1041. https://doi.org/10.1016/j.suc.2022.06.005

Pfledderer, C. D., Gren, L. H., Frost, C. J., Andrulis, I. L., Chung, W. K., Genkinger, J., Glendon, G., Hopper, J. L., John, E. M., Southey, M., Terry, M. B., & Daly, M. B. (2022). Women’s thoughts on receiving and sharing genetic information: Considerations for genetic counseling. Journal of Genetic Counseling, 31(6), 1249–1260. Portico. https://doi.org/10.1002/jgc4.1599

Kehm, R. D., Walter, E. J., Pereira, A., White, M. L., Oskar, S., Michels, K. B., Shepherd, J. A., Lilge, L., & Terry, M. B. (2022). A comparison of various methods for measuring breast density and breast tissue composition in adolescent girls and women. Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-17800-0

Kehm, R. D., Walter, E. J., Oskar, S., White, M. L., Tehranifar, P., Herbstman, J. B., Perera, F., Lilge, L., Miller, R. L., & Terry, M. B. (2022). Exposure to polycyclic aromatic hydrocarbons during pregnancy and breast tissue composition in adolescent daughters and their mothers: a prospective cohort study. Breast Cancer Research, 24(1). https://doi.org/10.1186/s13058-022-01546-8

Ahearn, T. U., Zhang, H., Michailidou, K., Milne, R. L., Bolla, M. K., Dennis, J., Dunning, A. M., Lush, M., Wang, Q., Andrulis, I. L., Anton-Culver, H., Arndt, V., Aronson, K. J., Auer, P. L., Augustinsson, A., Baten, A., Becher, H., Behrens, S., Benitez, J., … Chatterjee, N. (2022). Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Research, 24(1). https://doi.org/10.1186/s13058-021-01484-x

Jorgensen, K., Nitecki, R., Nichols, H. B., Fu, S., Wu, C.-F., Melamed, A., Brady, P., Chavez Mac Gregor, M., Clapp, M. A., Giordano, S., & Rauh-Hain, J. A. (2022). Obstetric and Neonatal Outcomes 1 or More Years After a Diagnosis of Breast Cancer. Obstetrics & Gynecology, 140(6), 939–949. https://doi.org/10.1097/aog.0000000000004936

Freedman, R. A., Ko, N. Y., Lederman, R. I., Gagnon, H., Fikre, T., Gundersen, D. A., Revette, A. C., Odai-Afotey, A., Kantor, O., Hershman, D. L., Crew, K. D., & Keating, N. L. (2022). Breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivors. Breast Cancer Research and Treatment, 196(3), 623–633. https://doi.org/10.1007/s10549-022-06752-8

Jennings, C., Wynn, J., Miguel, C., Levinson, E., Florido, M. E., White, M., Sands, C. B., Schwartz, L. A., Daly, M., O’Toole, K., Buys, S. S., Glendon, G., Hanna, D., Andrulis, I. L., Terry, M. B., Chung, W. K., & Bradbury, A. (2022). Mother and Daughter Perspectives on Genetic Counseling and Testing of Adolescents for Hereditary Breast Cancer Risk. The Journal of Pediatrics, 251, 113-119.e7. https://doi.org/10.1016/j.jpeds.2022.06.027

Jones, T., Silverman, T., Guzman, A., McGuinness, J. E., Trivedi, M. S., Kukafka, R., & Crew, K. D. (2022). Qualitative analysis of shared decision-making for chemoprevention in the primary care setting: provider-related barriers. BMC Medical Informatics and Decision Making, 22(1). https://doi.org/10.1186/s12911-022-01954-y

Filippone, M. G., Gaglio, D., Bonfanti, R., Tucci, F. A., Ceccacci, E., Pennisi, R., Bonanomi, M., Jodice, G., Tillhon, M., Montani, F., Bertalot, G., Freddi, S., Vecchi, M., Taglialatela, A., Romanenghi, M., Romeo, F., Bianco, N., Munzone, E., Sanguedolce, F., … Pece, S. (2022). CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-30375-8

Hamyoon, H., Yee Chan, W., Mohammadi, A., Yusuf Kuzan, T., Mirza-Aghazadeh-Attari, M., Leong, W. L., Murzoglu Altintoprak, K., Vijayananthan, A., Rahmat, K., Ab Mumin, N., Sam Leong, S., Ejtehadifar, S., Faeghi, F., Abolghasemi, J., Ciaccio, E. J., Rajendra Acharya, U., & Abbasian Ardakani, A. (2022). Artificial intelligence, BI-RADS evaluation and morphometry: A novel combination to diagnose breast cancer using ultrasonography, results from multi-center cohorts. European Journal of Radiology, 157, 110591. https://doi.org/10.1016/j.ejrad.2022.110591

Gleisner, A. L., Moss, A., Friedman, C., Suresh, K., Grunwald, G., Torphy, R. J., Leonard, L. D., Colborn, K., Ahrendt, G., Tevis, S., Christian, N., Abud, V. L., de Araujo, T. B., Beaty, L. E., Thieu, D., Glorioso, T. J., Kim, S., & Daugherty, S. (2020). De-implementation of Axillary Dissection in Women With Breast Cancer is Largely Driven By Site-level Contextual Effects. Annals of Surgery, 276(6), e923–e931. https://doi.org/10.1097/sla.0000000000004705

Ro, V., Jones, T., Silverman, T., McGuinness, J. E., Guzman, A., Amenta, J., Kukafka, R., & Crew, K. D. (2022). Patient, primary care provider, and stakeholder perspectives on mammography screening frequency: lessons learned from a qualitative study. BMC Cancer, 22(1). https://doi.org/10.1186/s12885-022-09900-x

Dennis, J., Tyrer, J. P., Walker, L. C., Michailidou, K., Dorling, L., Bolla, M. K., Wang, Q., Ahearn, T. U., Andrulis, I. L., Anton-Culver, H., Antonenkova, N. N., Arndt, V., Aronson, K. J., Freeman, L. E. B., Beckmann, M. W., Behrens, S., Benitez, J., Bermisheva, M., Bogdanova, N. V., … Easton, D. F. (2022). Rare germline copy number variants (CNVs) and breast cancer risk. Communications Biology, 5(1). https://doi.org/10.1038/s42003-021-02990-6

Hershman, D. L., Unger, J. M., Greenlee, H., Capodice, J., Lew, D. L., Darke, A., Minasian, L. M., Fisch, M. J., Henry, N. L., & Crew, K. D. (2022). Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain. JAMA Network Open, 5(11), e2241720. https://doi.org/10.1001/jamanetworkopen.2022.41720